The Programme aims to improve and promote health in the Union to reduce the burden of communicable and non-communicable diseases by:
Under the EU-USA collaboration on cancer, two technical working groups have been established, one focusing on paediatric cancer and the other on lung cancer. Each technical working group is progressing in defining a demonstration project, aiming at enhancing the EU-USA cooperation in paediatric and lung cancer domains.
The EU-USA cooperation on lung cancer aims to start a joint cohort modelling, to assess geographical distribution of tobacco prevalence and lung cancer burden, and to assess potential effects of lung cancer screening on mortality, based on different eligibility criteria for screening.
Through the collection of data with a harmonised methodology, the joint demonstration project on lung cancer will contribute to foster a uniform use and interpretation of data across EU and US involved participants on lung cancer screening. Considering the need for more and better data to identify and target higher risk lung cancer profiles, such as heavy smokers/ex-smokers, the aggregated results of the investigation have the objective to contribute in advancing the use and re-use of health data for research and innovation in lung cancer primary and secondary prevention policies.
Specific action-level indicators for reporting purposes:
The costs will be reimbursed at the funding rate fixed in the Grant Agreement (60%).
You can apply for a higher project funding rate (80%) if your project is of ‘exceptional utility’, i.e. concerns:
In order to be eligible, the applicants (beneficiaries and affiliated entities) must:
Other eligibility conditions:
Consortium composition: Applications may be either by a single applicant or a consortium (no minimum requirement).
Eligible activities: Applications will only be considered eligible if their content corresponds wholly (or at least in part) to the topic description for which they are submitted.
Geographic location (target countries): Proposals must relate to activities taking place in the eligible countries (see above).
Ministry of Health, Department of European Affairs
Ms MAKRIGIORGI Elena
Email: emakrigiorgi@moh.gov.cy
For help related to this call, please contact: HADEA-HP-CALLS@ec.europa.eu